{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T16:15:13Z","timestamp":1784304913475,"version":"3.55.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T00:00:00Z","timestamp":1750636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T00:00:00Z","timestamp":1750636800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Retin Vitr"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) are autoimmune disorders of the central nervous system with overlapping clinical manifestations but distinct treatments and prognoses. Imaging markers are necessary to differentiate between these disorders, especially when serologic testing is unavailable or unclear. Optical coherence tomography angiography (OCT-A) serves as a non-invasive imaging tool that assesses retinal microvascular alterations, potentially as a modality for differentiating MS and NMOSD. This review aimed to assess and consolidate evidence on retinal vascular alterations, measured by OCT-A, in people with MS (PwMS) and people with NMOSD (PwNMOSD) to help discriminate between these disorders.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>PubMed\/MEDLINE, Web of Science, Scopus, and Embase were systematically searched up to August 27, 2024, to identify original English studies that compared OCT-A parameters between PwMS and PwNMOSD. The risk of bias across studies was evaluated utilizing the Newcastle\u2013Ottawa Scale (NOS). Findings were consolidated using a narrative synthesis method.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Nine studies involving 181 PwMS and 166 PwNMOSD were included. Compared to PwMS, PwNMOSD exhibited significantly lower vessel densities in the peripapillary and macular regions, reduced radial peripapillary capillary (RPC) density, and smaller foveal avascular zone (FAZ) areas, particularly in optic neuritis (ON)-affected eyes. Minimal differences were observed in eyes without ON, suggesting that ON may be crucial when utilizing OCT-A biomarkers for disease discrimination.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>OCT-A metrics demonstrate potential as biomarkers that may help distinguish MS and NMOSD, with PwNMOSD showing more severe retinal vascular alterations. These preliminary findings highlight that OCT-A may hold promise as a diagnostic tool for differentiating MS and NMOSD. Further studies are needed to validate these findings.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s40942-025-00698-x","type":"journal-article","created":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T07:30:43Z","timestamp":1750663843000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Optical coherence tomography angiography biomarkers in multiple sclerosis and neuromyelitis optica spectrum disorders: a systematic review"],"prefix":"10.1186","volume":"11","author":[{"given":"Omid","family":"Mirmosayyeb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Yazdan Panah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Kord","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elahe","family":"Espoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed","family":"Vaheb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aram","family":"Zabeti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahid","family":"Shaygannejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,23]]},"reference":[{"issue":"1","key":"698_CR1","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/ene.13819","volume":"26","author":"R Dobson","year":"2019","unstructured":"Dobson R, Giovannoni G. Multiple sclerosis\u2013a review. Eur J Neurol. 2019;26(1):27\u201340.","journal-title":"Eur J Neurol"},{"key":"698_CR2","doi-asserted-by":"crossref","unstructured":"Gao Y, et al. Assessment of outer retina and choroid using swept source optical coherence tomography and angiography in patients with multiple sclerosis. J Neuroophthalmol. 2024;44(2):167\u201371.","DOI":"10.1097\/WNO.0000000000001970"},{"key":"698_CR3","doi-asserted-by":"crossref","unstructured":"Ree\u00df LG, et al. Barriers in healthcare to the use of optical coherence tomography angiography in multiple sclerosis. Neurol Therapy. 2025;14(1):45\u201356.","DOI":"10.1007\/s40120-024-00670-1"},{"issue":"1","key":"698_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00415-024-12827-x","volume":"272","author":"O Mirmosayyeb","year":"2025","unstructured":"Mirmosayyeb O, et al. Magnetic resonance imaging-based biomarkers of multiple sclerosis and neuromyelitis optica spectrum disorder: a systematic review and meta-analysis. J Neurol. 2025;272(1):1\u201325.","journal-title":"J Neurol"},{"key":"698_CR5","doi-asserted-by":"crossref","unstructured":"Sven J, et al. Neuromyelitis optica (Primer). Nat Reviews: Disease Primers. 2020;6(1).","DOI":"10.1038\/s41572-020-00225-2"},{"key":"698_CR6","first-page":"e334","volume-title":"Microstructural visual system changes in AQP4-antibody\u2013seropositive NMOSD","author":"FC Oertel","year":"2017","unstructured":"Oertel FC, et al. Microstructural visual system changes in AQP4-antibody\u2013seropositive NMOSD. Neurology: Neuroimmunology & Neuroinflammation. 2017;4(3):e334."},{"key":"698_CR7","doi-asserted-by":"publisher","first-page":"103503","DOI":"10.1016\/j.msard.2022.103503","volume":"58","author":"BI Tiftikcioglu","year":"2022","unstructured":"Tiftikcioglu BI, et al. Optical coherence tomography angiography (OCTA) in differential diagnosis of aquaporin-4 antibody seronegative NMOSD and multiple sclerosis. Multiple Scler Relat Disorders. 2022;58:103503.","journal-title":"Multiple Scler Relat Disorders"},{"issue":"1","key":"698_CR8","first-page":"735486","volume":"2012","author":"W Kim","year":"2012","unstructured":"Kim W, et al. Brain abnormalities in neuromyelitis optica spectrum disorder. Multiple Scler Int. 2012;2012(1):735486.","journal-title":"Multiple Scler Int"},{"key":"698_CR9","doi-asserted-by":"publisher","first-page":"1417814","DOI":"10.3389\/fneur.2024.1417814","volume":"15","author":"X Wang","year":"2024","unstructured":"Wang X, Bao L. Comparison of ocular changes in multiple sclerosis and neuromyelitis optica spectrum disorder patients. Front Neurol. 2024;15:1417814.","journal-title":"Front Neurol"},{"issue":"9","key":"698_CR10","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/nrneurol.2014.141","volume":"10","author":"MC Papadopoulos","year":"2014","unstructured":"Papadopoulos MC, Bennett JL, Verkman AS. Treatment of neuromyelitis optica: state-of-the-art and emerging therapies. Nat Reviews Neurol. 2014;10(9):493\u2013506.","journal-title":"Nat Reviews Neurol"},{"issue":"1","key":"698_CR11","doi-asserted-by":"publisher","first-page":"11625","DOI":"10.1038\/s41598-023-38271-x","volume":"13","author":"JM Seok","year":"2023","unstructured":"Seok JM, et al. Differentiation between multiple sclerosis and neuromyelitis optica spectrum disorder using a deep learning model. Sci Rep. 2023;13(1):11625.","journal-title":"Sci Rep"},{"issue":"2","key":"698_CR12","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1177\/1352458517750009","volume":"25","author":"N Feucht","year":"2019","unstructured":"Feucht N, et al. Optical coherence tomography angiography indicates associations of the retinal vascular network and disease activity in multiple sclerosis. Multiple Scler J. 2019;25(2):224\u201334.","journal-title":"Multiple Scler J"},{"issue":"7","key":"698_CR13","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1177\/1352458519845116","volume":"26","author":"OC Murphy","year":"2020","unstructured":"Murphy OC, et al. Alterations in the retinal vasculature occur in multiple sclerosis and exhibit novel correlations with disability and visual function measures. Multiple Scler J. 2020;26(7):815\u201328.","journal-title":"Multiple Scler J"},{"key":"698_CR14","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ajo.2018.04.026","volume":"192","author":"WR Kwapong","year":"2018","unstructured":"Kwapong WR, et al. Altered macular microvasculature in neuromyelitis optica spectrum disorders. Am J Ophthalmol. 2018;192:47\u201355.","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"698_CR15","doi-asserted-by":"publisher","first-page":"205521731879119","DOI":"10.1177\/2055217318791196","volume":"4","author":"J Srikajon","year":"2018","unstructured":"Srikajon J, et al. Differences in clinical features between optic neuritis in neuromyelitis optica spectrum disorders and in multiple sclerosis. Multiple Scler Journal\u2013Experimental Translational Clin. 2018;4(3):2055217318791196.","journal-title":"Multiple Scler Journal\u2013Experimental Translational Clin"},{"key":"698_CR16","doi-asserted-by":"crossref","unstructured":"Savastano MC, et al. Optical coherence tomography advanced parameters in patients with multiple sclerosis: ophthalmological and neurological assessments. American Journal of Ophthalmology; 2024.","DOI":"10.1016\/j.ajo.2024.06.011"},{"issue":"4","key":"698_CR17","doi-asserted-by":"publisher","first-page":"4710","DOI":"10.1364\/OE.20.004710","volume":"20","author":"Y Jia","year":"2012","unstructured":"Jia Y, et al. Split-spectrum amplitude-decorrelation angiography with optical coherence tomography. Opt Express. 2012;20(4):4710\u201325.","journal-title":"Opt Express"},{"issue":"1","key":"698_CR18","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1136\/bjophthalmol-2016-309389","volume":"101","author":"A Koustenis","year":"2017","unstructured":"Koustenis A, et al. Optical coherence tomography angiography: an overview of the technology and an assessment of applications for clinical research. Br J Ophthalmol. 2017;101(1):16\u201320.","journal-title":"Br J Ophthalmol"},{"key":"698_CR19","doi-asserted-by":"publisher","first-page":"604049","DOI":"10.3389\/fneur.2020.604049","volume":"11","author":"I Kleerekooper","year":"2020","unstructured":"Kleerekooper I, et al. Optical coherence tomography angiography (OCTA) in multiple sclerosis and neuromyelitis optica spectrum disorder. Front Neurol. 2020;11:604049.","journal-title":"Front Neurol"},{"key":"698_CR20","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3389\/fneur.2020.00035","volume":"11","author":"Y Chen","year":"2020","unstructured":"Chen Y, et al. The detection of retina microvascular density in subclinical aquaporin-4 antibody seropositive neuromyelitis optica spectrum disorders. Front Neurol. 2020;11:35.","journal-title":"Front Neurol"},{"key":"698_CR21","doi-asserted-by":"publisher","first-page":"105478","DOI":"10.1016\/j.msard.2024.105478","volume":"85","author":"C Liu","year":"2024","unstructured":"Liu C, et al. Combination of serum markers with optical coherence tomography angiography for evaluating neuromyelitis optica spectrum disorders and multiple sclerosis. Multiple Scler Relat Disorders. 2024;85:105478.","journal-title":"Multiple Scler Relat Disorders"},{"key":"698_CR22","doi-asserted-by":"publisher","first-page":"102780","DOI":"10.1016\/j.msard.2021.102780","volume":"49","author":"G-I Lee","year":"2021","unstructured":"Lee G-I, et al. Differential patterns of parafoveal and peripapillary vessel density in multiple sclerosis and neuromyelitis optica spectrum disorder. Multiple Scler Relat Disorders. 2021;49:102780.","journal-title":"Multiple Scler Relat Disorders"},{"key":"698_CR23","doi-asserted-by":"crossref","unstructured":"Page MJ, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372.","DOI":"10.1136\/bmj.n71"},{"issue":"2","key":"698_CR24","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/ana.22366","volume":"69","author":"CH Polman","year":"2011","unstructured":"Polman CH, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011;69(2):292\u2013302.","journal-title":"Ann Neurol"},{"issue":"2","key":"698_CR25","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson AJ, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17(2):162\u201373.","journal-title":"Lancet Neurol"},{"issue":"2","key":"698_CR26","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","volume":"85","author":"DM Wingerchuk","year":"2015","unstructured":"Wingerchuk DM, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015;85(2):177\u201389.","journal-title":"Neurology"},{"key":"698_CR27","first-page":"1","volume-title":"The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses","author":"J Peterson","year":"2011","unstructured":"Peterson J, et al. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa: Ottawa Hospital Research Institute. 2011;2(1):1\u201312."},{"issue":"6","key":"698_CR28","doi-asserted-by":"publisher","first-page":"e3009","DOI":"10.1002\/brb3.3009","volume":"13","author":"C Ezegbe","year":"2023","unstructured":"Ezegbe C, et al. Instruments measuring change in cognitive function in multiple sclerosis: a systematic review. Brain Behav. 2023;13(6):e3009.","journal-title":"Brain Behav"},{"key":"698_CR29","unstructured":"Popay J. Guidance on the conduct of narrative synthesis in systematic reviews. ESRC Methods Programme; 2006."},{"issue":"6","key":"698_CR30","doi-asserted-by":"publisher","first-page":"e0253417","DOI":"10.1371\/journal.pone.0253417","volume":"16","author":"M Rogaczewska","year":"2021","unstructured":"Rogaczewska M, Michalak S, Stopa M. Macular vessel density differs in multiple sclerosis and neuromyelitis optica spectrum disorder: an optical coherence tomography angiography study. PLoS ONE. 2021;16(6):e0253417.","journal-title":"PLoS ONE"},{"issue":"1","key":"698_CR31","doi-asserted-by":"publisher","first-page":"10697","DOI":"10.1038\/s41598-021-90036-6","volume":"11","author":"M Rogaczewska","year":"2021","unstructured":"Rogaczewska M, Michalak S, Stopa M. Differentiation between multiple sclerosis and neuromyelitis optica spectrum disorder using optical coherence tomography angiography. Sci Rep. 2021;11(1):10697.","journal-title":"Sci Rep"},{"issue":"4","key":"698_CR32","doi-asserted-by":"publisher","first-page":"609","DOI":"10.3390\/jcm10040609","volume":"10","author":"M Rogaczewska","year":"2021","unstructured":"Rogaczewska M, Michalak S, Stopa M. Optical coherence tomography angiography of peripapillary vessel density in multiple sclerosis and neuromyelitis optica spectrum disorder: a comparative study. J Clin Med. 2021;10(4):609.","journal-title":"J Clin Med"},{"issue":"2","key":"698_CR33","doi-asserted-by":"publisher","first-page":"96","DOI":"10.5114\/ko.2021.105629","volume":"123","author":"M Rogaczewska","year":"2021","unstructured":"Rogaczewska M, Michalak S, Stopa M. Color vision impairment in multiple sclerosis and neuromyelitis optica spectrum disorder. Klinika Oczna\/Acta Ophthalmol Pol. 2021;123(2):96\u2013101.","journal-title":"Klinika Oczna\/Acta Ophthalmol Pol"},{"issue":"5","key":"698_CR34","doi-asserted-by":"publisher","first-page":"e02125","DOI":"10.1002\/brb3.2125","volume":"11","author":"C Liu","year":"2021","unstructured":"Liu C, et al. Optical coherence tomography angiography helps distinguish multiple sclerosis from AQP4-IgG\u2010seropositive neuromyelitis optica spectrum disorder. Brain Behav. 2021;11(5):e02125.","journal-title":"Brain Behav"},{"issue":"4","key":"698_CR35","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1177\/13524585211028831","volume":"28","author":"L Aly","year":"2022","unstructured":"Aly L, et al. Optical coherence tomography angiography indicates subclinical retinal disease in neuromyelitis optica spectrum disorders. Multiple Scler J. 2022;28(4):522\u201331.","journal-title":"Multiple Scler J"},{"issue":"10","key":"698_CR36","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1136\/bjophthalmol-2013-304547","volume":"98","author":"X Wang","year":"2014","unstructured":"Wang X, et al. Optical coherence tomography angiography of optic nerve head and parafovea in multiple sclerosis. Br J Ophthalmol. 2014;98(10):1368\u201373.","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"698_CR37","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1364\/BOE.7.002321","volume":"7","author":"B Bhaduri","year":"2016","unstructured":"Bhaduri B, et al. Detection of retinal blood vessel changes in multiple sclerosis with optical coherence tomography. Biomedical Opt Express. 2016;7(6):2321\u201330.","journal-title":"Biomedical Opt Express"},{"issue":"13","key":"698_CR38","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1177\/1352458517729463","volume":"24","author":"R Lanzillo","year":"2018","unstructured":"Lanzillo R, et al. Optical coherence tomography angiography retinal vascular network assessment in multiple sclerosis. Multiple Scler J. 2018;24(13):1706\u201314.","journal-title":"Multiple Scler J"},{"issue":"4","key":"698_CR39","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1136\/bjophthalmol-2017-310477","volume":"102","author":"RI Spain","year":"2018","unstructured":"Spain RI, et al. Optical coherence tomography angiography enhances the detection of optic nerve damage in multiple sclerosis. Br J Ophthalmol. 2018;102(4):520\u20134.","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"698_CR40","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1136\/bjophthalmol-2018-312231","volume":"103","author":"Y Huang","year":"2019","unstructured":"Huang Y, et al. Peripapillary and parafoveal vascular network assessment by optical coherence tomography angiography in aquaporin-4 antibody-positive neuromyelitis optica spectrum disorders. Br J Ophthalmol. 2019;103(6):789\u201396.","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"698_CR41","doi-asserted-by":"publisher","first-page":"10371","DOI":"10.1038\/s41598-019-46251-3","volume":"9","author":"M Vabanesi","year":"2019","unstructured":"Vabanesi M, et al. In vivo structural and functional assessment of optic nerve damage in neuromyelitis optica spectrum disorders and multiple sclerosis. Sci Rep. 2019;9(1):10371.","journal-title":"Sci Rep"},{"issue":"3","key":"698_CR42","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.ophtha.2018.06.022","volume":"126","author":"T Shen","year":"2019","unstructured":"Shen T, et al. Differing structural and functional patterns of optic nerve damage in multiple sclerosis and neuromyelitis optica spectrum disorder. Ophthalmology. 2019;126(3):445\u201353.","journal-title":"Ophthalmology"},{"issue":"1","key":"698_CR43","doi-asserted-by":"publisher","first-page":"e57","DOI":"10.1111\/aos.12215","volume":"92","author":"KA Park","year":"2014","unstructured":"Park KA, Kim J, Oh SY. Analysis of spectral domain optical coherence tomography measurements in optic neuritis: differences in neuromyelitis optica, multiple sclerosis, isolated optic neuritis and normal healthy controls. Acta Ophthalmol. 2014;92(1):e57\u201365.","journal-title":"Acta Ophthalmol"},{"issue":"6","key":"698_CR44","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1177\/1352458514567216","volume":"21","author":"JL Bennett","year":"2015","unstructured":"Bennett JL, et al. Neuromyelitis optica and multiple sclerosis: seeing differences through optical coherence tomography. Multiple Scler J. 2015;21(6):678\u201388.","journal-title":"Multiple Scler J"},{"issue":"9","key":"698_CR45","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1136\/jnnp.2008.166207","volume":"80","author":"AJ Green","year":"2009","unstructured":"Green AJ, Cree BA. Distinctive retinal nerve fibre layer and vascular changes in neuromyelitis optica following optic neuritis. J Neurol Neurosurg Psychiatry. 2009;80(9):1002\u20135.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"698_CR46","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.preteyeres.2008.04.001","volume":"27","author":"A Verkman","year":"2008","unstructured":"Verkman A, Ruiz-Ederra J, Levin MH. Functions of aquaporins in the eye. Prog Retin Eye Res. 2008;27(4):420\u201333.","journal-title":"Prog Retin Eye Res"},{"issue":"7","key":"698_CR47","first-page":"1086","volume":"28","author":"RN Frank","year":"1987","unstructured":"Frank RN, Dutta S, Mancini MA. Pericyte coverage is greater in the retinal than in the cerebral capillaries of the rat. Investig Ophthalmol Vis Sci. 1987;28(7):1086\u201391.","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"9","key":"698_CR48","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","volume":"6","author":"DM Wingerchuk","year":"2007","unstructured":"Wingerchuk DM, et al. The spectrum of neuromyelitis optica. Lancet Neurol. 2007;6(9):805\u201315.","journal-title":"Lancet Neurol"},{"key":"698_CR49","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1023\/A:1007677003387","volume":"25","author":"LF Eng","year":"2000","unstructured":"Eng LF, Ghirnikar RS, Lee YL. Glial fibrillary acidic protein: GFAP-thirty-one years (1969\u20132000). Neurochem Res. 2000;25:1439\u201351.","journal-title":"Neurochem Res"},{"issue":"5","key":"698_CR50","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1093\/brain\/awm047","volume":"130","author":"T Misu","year":"2007","unstructured":"Misu T, et al. Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis. Brain. 2007;130(5):1224\u201334.","journal-title":"Brain"},{"issue":"10","key":"698_CR51","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1177\/1352458510382324","volume":"16","author":"JD Parratt","year":"2010","unstructured":"Parratt JD, Prineas JW. Neuromyelitis optica: a demyelinating disease characterized by acute destruction and regeneration of perivascular astrocytes. Multiple Scler J. 2010;16(10):1156\u201372.","journal-title":"Multiple Scler J"},{"key":"698_CR52","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.neuroscience.2015.03.064","volume":"323","author":"JA Filosa","year":"2016","unstructured":"Filosa JA, et al. Beyond neurovascular coupling, role of astrocytes in the regulation of vascular tone. Neuroscience. 2016;323:96\u2013109.","journal-title":"Neuroscience"},{"issue":"1","key":"698_CR53","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1152\/japplphysiol.00938.2005","volume":"100","author":"RC Koehler","year":"2006","unstructured":"Koehler RC, Gebremedhin D, Harder DR. Role of astrocytes in cerebrovascular regulation. J Appl Physiol. 2006;100(1):307\u201317.","journal-title":"J Appl Physiol"},{"key":"698_CR54","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3389\/fncel.2013.00038","volume":"7","author":"JL Stobart","year":"2013","unstructured":"Stobart JL, Anderson CM. Multifunctional role of astrocytes as gatekeepers of neuronal energy supply. Front Cell Neurosci. 2013;7:38.","journal-title":"Front Cell Neurosci"},{"issue":"10","key":"698_CR55","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1001\/jamaneurol.2014.1668","volume":"71","author":"O Marshall","year":"2014","unstructured":"Marshall O, et al. Impaired cerebrovascular reactivity in multiple sclerosis. JAMA Neurol. 2014;71(10):1275\u201381.","journal-title":"JAMA Neurol"},{"issue":"23","key":"698_CR56","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1212\/WNL.0b013e318200d80c","volume":"75","author":"BG Popescu","year":"2010","unstructured":"Popescu BG, et al. Absence of cortical demyelination in neuromyelitis optica. Neurology. 2010;75(23):2103\u20139.","journal-title":"Neurology"},{"issue":"1","key":"698_CR57","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/ana.23721","volume":"73","author":"E Saji","year":"2013","unstructured":"Saji E, et al. Cognitive impairment and cortical degeneration in neuromyelitis optica. Ann Neurol. 2013;73(1):65\u201376.","journal-title":"Ann Neurol"},{"key":"698_CR58","first-page":"e311","volume-title":"Effects of neuromyelitis optica\u2013IgG at the blood\u2013brain barrier in vitro","author":"Y Takeshita","year":"2016","unstructured":"Takeshita Y, et al. Effects of neuromyelitis optica\u2013IgG at the blood\u2013brain barrier in vitro. Neurology: Neuroimmunology & Neuroinflammation. 2016;4(1):e311."},{"issue":"4","key":"698_CR59","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1111\/apha.12250","volume":"210","author":"V Muoio","year":"2014","unstructured":"Muoio V, Persson P, Sendeski M. The neurovascular unit\u2013concept review. Acta Physiol. 2014;210(4):790\u20138.","journal-title":"Acta Physiol"},{"issue":"3","key":"698_CR60","doi-asserted-by":"publisher","first-page":"223","DOI":"10.3325\/cmj.2016.57.223","volume":"57","author":"P Venkat","year":"2016","unstructured":"Venkat P, Chopp M, Chen J. New insights into coupling and uncoupling of cerebral blood flow and metabolism in the brain. Croatian Med J. 2016;57(3):223\u20138.","journal-title":"Croatian Med J"},{"issue":"12","key":"698_CR61","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1038\/nm1210-1370","volume":"16","author":"BV Zlokovic","year":"2010","unstructured":"Zlokovic BV. Neurodegeneration and the neurovascular unit. Nat Med. 2010;16(12):1370\u20131.","journal-title":"Nat Med"},{"key":"698_CR62","doi-asserted-by":"crossref","unstructured":"Yamamura T, Nakashima I. Foveal thinning in neuromyelitis optica: A sign of retinal astrocytopathy? 2017, AAN Enterprises. p. e347.","DOI":"10.1212\/NXI.0000000000000347"},{"issue":"9","key":"698_CR63","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1177\/1352458520964409","volume":"27","author":"RA Bermel","year":"2021","unstructured":"Bermel RA, et al. Optical coherence tomography outcomes from SPRINT-MS, a multicenter, randomized, double-blind trial of ibudilast in progressive multiple sclerosis. Multiple Scler J. 2021;27(9):1384\u201390.","journal-title":"Multiple Scler J"},{"issue":"11","key":"698_CR64","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1177\/1352458520977771","volume":"27","author":"AG Filippatou","year":"2021","unstructured":"Filippatou AG, et al. Evidence of subclinical quantitative retinal layer abnormalities in AQP4-IgG seropositive NMOSD. Multiple Scler J. 2021;27(11):1738\u201348.","journal-title":"Multiple Scler J"},{"issue":"2","key":"698_CR65","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1177\/1352458518768060","volume":"25","author":"R Lanzillo","year":"2019","unstructured":"Lanzillo R, et al. Optical coherence tomography angiography detects retinal vascular alterations in different phases of multiple sclerosis. Multiple Scler J. 2019;25(2):300\u20131.","journal-title":"Multiple Scler J"},{"issue":"1","key":"698_CR66","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1111\/ene.13770","volume":"26","author":"R Lanzillo","year":"2019","unstructured":"Lanzillo R, et al. Retinal vascular density in multiple sclerosis: a 1-year follow\u2010up. Eur J Neurol. 2019;26(1):198\u2013201.","journal-title":"Eur J Neurol"},{"issue":"3","key":"698_CR67","first-page":"86","volume":"3","author":"F Chirico","year":"2023","unstructured":"Chirico F. Cross-sectional studies in occupational health research: an overview of strengths and limitations. G Ital Psicol Med Lav. 2023;3(3):86\u201393.","journal-title":"G Ital Psicol Med Lav"}],"container-title":["International Journal of Retina and Vitreous"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-025-00698-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40942-025-00698-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-025-00698-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T20:02:00Z","timestamp":1750708920000},"score":1,"resource":{"primary":{"URL":"https:\/\/journalretinavitreous.biomedcentral.com\/articles\/10.1186\/s40942-025-00698-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,23]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["698"],"URL":"https:\/\/doi.org\/10.1186\/s40942-025-00698-x","relation":{},"ISSN":["2056-9920"],"issn-type":[{"value":"2056-9920","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,23]]},"assertion":[{"value":"30 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"During the preparation of this work the authors used Chat-GPT in order to improve the readability and language of the manuscript. After using this service, the authors reviewed and edited the content as needed and take full responsibility for the content of the published article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of generative AI and AI-assisted technologies in the writing process"}}],"article-number":"71"}}